BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20122448)

  • 1. Insulin-like growth factor I and insulin and their abuse in sport.
    Erotokritou-Mulligan I; Holt RI
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):33-43, viii. PubMed ID: 20122448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I abuse in sport: current knowledge and future prospects for detection.
    Guha N; Sönksen PH; Holt RI
    Growth Horm IGF Res; 2009 Aug; 19(4):408-11. PubMed ID: 19467615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport.
    Nelson AE; Ho KK
    Growth Horm IGF Res; 2009 Aug; 19(4):327-32. PubMed ID: 19481485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
    Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
    J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-I abuse in sport.
    Guha N; Dashwood A; Thomas NJ; Skingle AJ; Sönksen PH; Holt RI
    Curr Drug Abuse Rev; 2009 Sep; 2(3):263-72. PubMed ID: 20443773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting growth hormone abuse in athletes.
    Bidlingmaier M; Manolopoulou J
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):25-32, vii. PubMed ID: 20122447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry.
    Bredehöft M; Schänzer W; Thevis M
    Rapid Commun Mass Spectrom; 2008; 22(4):477-85. PubMed ID: 18236437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone, IGF-I and insulin and their abuse in sport.
    Holt RI; Sönksen PH
    Br J Pharmacol; 2008 Jun; 154(3):542-56. PubMed ID: 18376417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Growth hormone and IGF-1 as doping agents in competitive sport].
    Jóźków P; Medraś M
    Endokrynol Pol; 2009; 60(5):389-94. PubMed ID: 19885810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.
    Guha N; Cowan DA; Sönksen PH; Holt RI
    Anal Bioanal Chem; 2013 Dec; 405(30):9669-83. PubMed ID: 23934394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
    Saukkonen T; Shojaee-Moradie F; Williams RM; Amin R; Yuen KC; Watts A; Acerini CL; Umpleby AM; Dunger DB
    Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent?
    Rogol AD
    Growth Horm IGF Res; 2009 Aug; 19(4):294-9. PubMed ID: 19487146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids].
    Vondra K; Hampl R; Nĕmcová D; Hill M; Hoza J; Kot'átková A; Stárka L; Vrbíková J; Zamrazil V
    Cas Lek Cesk; 2002 Feb; 141(3):89-95. PubMed ID: 11925670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) in nutritional status].
    Chevenne D; Porquet D
    Ann Biol Clin (Paris); 1995; 53(10-11):527-38. PubMed ID: 8787278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
    Yuen KC; Dunger DB
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New detection methods of growth hormone and growth factors.
    Bidlingmaier M
    Endocr Dev; 2012; 23():52-9. PubMed ID: 23182820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving one step closer to catching the GH cheats: The GH-2004 experience.
    Holt RI; Bassett EE; Erotokritou-Mulligan I; McHugh C; Cowan D; Bartlett C; Sönksen PH;
    Growth Horm IGF Res; 2009 Aug; 19(4):346-51. PubMed ID: 19467613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The physiology of growth hormone and sport.
    Widdowson WM; Healy ML; Sönksen PH; Gibney J
    Growth Horm IGF Res; 2009 Aug; 19(4):308-19. PubMed ID: 19505835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I, but not growth hormone, is dependent on a high protein intake to increase nitrogen balance in the rat.
    Sánchez-Gómez M; Malmlöf K; Mejía W; Bermudez A; Ochoa MT; Carrasco-Rodríguez S; Skottner A
    Br J Nutr; 1999 Feb; 81(2):145-52. PubMed ID: 10450333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.